FMCG · NSE: CUPID
Cupid
Q2 FY27 earnings highlights, from the results presentation
Q2 FY27 · From the investor presentation
- M.Cap
- ₹48,663Cr
- P/E
- 287.2×
- 1Y return
- +478.39%
- From 52W high
- −7.9%
Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.
Share price
Guidance
H2 FY27 expected stronger than H1 as Palava is commissioned in Q3
Slides · Chairman & Managing Director · p. 17
H2 FY27 expected stronger than H1 as Palava is commissioned in Q3
“We expect H2 FY27 to be stronger than H1, as Palava is to be commissioned in Q3 and both partnerships scale up.”
More figures from the presentation
“+770 Million male / +75 Million female condoms p.a.”
“480 Million → ~1.25 Billion”
“52 Million → ~125 Million”
In short
- 01FY27 guidance raised to at least Rs 880 crore revenue and Rs 275 crore+ net profit.
- 02Medium-term guidance: FY28 revenue Rs 1,305 crore+ and FY29 Rs 1,950 crore+, with net profit about Rs 390 crore and Rs 605 crore.
- 03H1 FY27 operating income grew 137% to Rs 342.58 crore; Q2 revenue rose 122% year on year.
- 04H2 FY27 expected stronger than H1, with Palava to be commissioned in Q3 FY27.
- 05Style Baazar expected to add about Rs 200 crore in FY27; V2 Retail seen as a Rs 400 crore opportunity over 12 months.
- 06Palava adds 770 million male and 75 million female condoms a year, taking male capacity to about 1.25 billion.
- 07Management says it will make the company debt-free over time.
Capex
Palava plant of about 170,000 sq ft, latex and nitrile, targeted for Q3 FY27
Slides · p. 32
Palava plant of about 170,000 sq ft, latex and nitrile, targeted for Q3 FY27
“~170,000 sq. ft.; latex + nitrile; Q3 FY27”
Capacity
IVD: IVD kit capacity to go from about 4 lakh to about 8 lakh kits a day
Slides · p. 32
IVD: IVD kit capacity to go from about 4 lakh to about 8 lakh kits a day
“Kits/day: ~4 Lakhs → ~8 Lakhs”
Order book
Exports: Long-term PFSCM supply agreement from Q1 FY27
Slides · p. 34
Exports: Long-term PFSCM supply agreement from Q1 FY27
“Long-term PFSCM supply agreement from Q1 FY27 (Mar 2026)”
Exports: South Africa programme 2025-30 worth about US$12.98 million a year
Slides · p. 34
Exports: South Africa programme 2025-30 worth about US$12.98 million a year
“South Africa programme 2025–30: ~US$12.98 Million p.a.”
Exports: South Africa programme: 23.4 million female condoms a year
Slides · p. 21
Exports: South Africa programme: 23.4 million female condoms a year
“– 23.4 Million female condoms p.a.”
Segments
Domestic FMCG: Style Baazar expected to contribute about Rs 200 crore in FY27
Slides · Chairman & Managing Director · p. 17
Domestic FMCG: Style Baazar expected to contribute about Rs 200 crore in FY27
“Style Baazar is expected to contribute about ₹200 crore in FY27”
Domestic FMCG: V2 Retail seen as about Rs 400 crore opportunity over next 12 months
Slides · Chairman & Managing Director · p. 17
Domestic FMCG: V2 Retail seen as about Rs 400 crore opportunity over next 12 months
“V2 Retail offers an estimated ₹400 crore opportunity over the next 12 months.”
Domestic FMCG: Style Baazar network to exceed 500 stores in 2-3 years
Slides · p. 25
Domestic FMCG: Style Baazar network to exceed 500 stores in 2-3 years
“● Style Baazar network to exceed 500 stores in 2–3 years”
IVD: IVD: State Government orders expected
Slides · p. 23
IVD: IVD: State Government orders expected
“State Government orders expected”
Exports: H1 FY27 exports Rs 112.73 crore (33.4%); domestic Rs 224.64 crore (66.6%)
Slides · p. 10
Exports: H1 FY27 exports Rs 112.73 crore (33.4%); domestic Rs 224.64 crore (66.6%)
“₹112.73 Crores 33.4% ₹224.64 Crores 66.6%”
Margins and costs
Q2 FY27 EBITDA Rs 54.77 crore, down 8.8% from Rs 60.06 crore in Q1
Slides · p. 16
Q2 FY27 EBITDA Rs 54.77 crore, down 8.8% from Rs 60.06 crore in Q1
“EBITDA 54.77 60.06 (8.8)% 28.41 92.8% 114.83 44.89 155.8%”
Exports: Minimum 10% price increase implemented
Slides · p. 13
Exports: Minimum 10% price increase implemented
“Minimum 10% price increase implemented”
H1 FY27 EBITDA margin 33.5%
Slides · p. 12
H1 FY27 EBITDA margin 33.5%
“H1 FY27 33.5%”
Q2 FY27 raw material cost Rs 97.38 crore, up 184.4% year on year
Slides · p. 16
Q2 FY27 raw material cost Rs 97.38 crore, up 184.4% year on year
“Raw material & changes in inventories 97.38 64.79 50.3% 34.24 184.4% 162.17 58.33 178.0%”
Debt and working capital
Management says it will make the company debt-free over time
Slides · Chairman & Managing Director · p. 17
Management says it will make the company debt-free over time
“will make the Company debt-free as we go along.”
FY26 current borrowings Rs 38.81 crore, up from Rs 12.63 crore
Slides · p. 44
FY26 current borrowings Rs 38.81 crore, up from Rs 12.63 crore
“Current borrowings 12.06 12.63 38.81”
FY26 cash and bank balances Rs 186.45 crore
Slides · p. 44
FY26 cash and bank balances Rs 186.45 crore
“Cash & bank balances 39.45 68.57 186.45”
FY26 non-current borrowings Rs 12.17 crore, nil in FY24 and FY25
Slides · p. 44
FY26 non-current borrowings Rs 12.17 crore, nil in FY24 and FY25
“Non-current borrowings – – 12.17”
Acquisitions and new business
South Africa: South Africa manufacturing venture is asset-light, Cupid stake up to 49%
Slides · p. 32
South Africa: South Africa manufacturing venture is asset-light, Cupid stake up to 49%
“Asset-light; Cupid stake up to 49%”
South Africa: Partner to fund capex and working capital of South Africa venture
Slides · p. 32
South Africa: Partner to fund capex and working capital of South Africa venture
“Partner funds capex & working capital”
West Bengal: West Bengal project: land and feasibility under evaluation
Slides · p. 32
West Bengal: West Bengal project: land and feasibility under evaluation
“Land & feasibility under evaluation”
56 lakh Baazar Style warrants still pending
Slides · p. 34
56 lakh Baazar Style warrants still pending
“56 Lakhs pending; ₹193.67 Crores”
Follow-on investment made in July 2026
Slides · p. 34
Follow-on investment made in July 2026
“Follow-on investment (Jul 2026)”
Other
H1 FY27 operating income grew 137% to Rs 342.58 crore
Slides · Chairman & Managing Director · p. 17
H1 FY27 operating income grew 137% to Rs 342.58 crore
“H1 FY27 reflects strong business momentum: operating income grew 137% to ₹342.58”
H1 FY27 net profit rose 156% to Rs 100.37 crore
Slides · Chairman & Managing Director · p. 17
H1 FY27 net profit rose 156% to Rs 100.37 crore
“net profit rose 156% to ₹100.37 crore.”
Q2 FY27 revenue up 122%, EBITDA up 93%, PAT up 133% year on year
Slides · p. 14
Q2 FY27 revenue up 122%, EBITDA up 93%, PAT up 133% year on year
“Q2 FY27 vs Q2 FY26: revenue +122%, EBITDA +93%, PAT +133%.”
Domestic Consumer Healthcare & FMCG: Domestic consumer healthcare and FMCG was 49% of H1 revenue
Slides · Chairman & Managing Director · p. 17
Domestic Consumer Healthcare & FMCG: Domestic consumer healthcare and FMCG was 49% of H1 revenue
“Domestic Consumer Healthcare & FMCG contributed 49% of H1 revenue”
Revenue guidance up 47% from the original
Slides · p. 18
Revenue guidance up 47% from the original
“▲ Revenue guidance up 47% from the original”
Sources
- Investor presentation, Q2 FY27 Filed 11 Nov 2026 · 53 pages
Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

